APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biosimulation Software

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biosimulation Software Industry Growth and Trends Forecast to 2032

5 June 2026121 pages

Choose your research edition.

Industry ResearchBiosimulation Software Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Biosimulation Software Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Biosimulation Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biosimulation Software Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Biosimulation Software Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

According to APO Research, the global Biosimulation Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biosimulation Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biosimulation Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biosimulation Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Biosimulation Software market include Certara, Simulations, Dassault Systèmes, Schrödinger, Advanced Chemistry, Chemical Computing, Rosa & Co., Genedata and Physiomics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biosimulation Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biosimulation Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biosimulation Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biosimulation Software.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Biosimulation Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biosimulation Software Market by Company

Certara

Simulations

Dassault Systèmes

Schrödinger

Advanced Chemistry

Chemical Computing

Rosa & Co.

Genedata

Physiomics

In Silico Biosciences

Allucent

OpenEye (Cadence)

Cellworks Group

VeriSIM Life

Netabolics SRL

Charnwood Discovery

The MathWorks

ANSYS

Instem Group of Companies

Insilico Medicine

SCM

BioSymetrics

Atomwise

insitro

Clinithink

Biosimulation Software Segment by Type

Independent Modules

Integrated Software Platform

Biosimulation Software Segment by Application

Pharmaceuticals

Medical Research

Others

Biosimulation Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosimulation Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biosimulation Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosimulation Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Biosimulation Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Biosimulation Software Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Biosimulation Software Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Biosimulation Software Market Share by Region (2021-2026) Table 4. Global Biosimulation Software Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Biosimulation Software Market Share by Region (2027-2032) Table 6. Global Biosimulation Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biosimulation Software Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Biosimulation Software Market Size Share by Type (2021-2026) Table 9. Global Biosimulation Software Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Biosimulation Software Market Size Share Forecasted by Type (2027-2032) Table 11. North America Biosimulation Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Biosimulation Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Biosimulation Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Biosimulation Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Biosimulation Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Biosimulation Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Biosimulation Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Biosimulation Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Biosimulation Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Biosimulation Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Biosimulation Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Biosimulation Software Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Biosimulation Software Market Size Share by Application (2021-2026) Table 24. Global Biosimulation Software Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Biosimulation Software Market Size Share Forecasted by Application (2027-2032) Table 26. North America Biosimulation Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Biosimulation Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Biosimulation Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Biosimulation Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Biosimulation Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Biosimulation Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Biosimulation Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Biosimulation Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Biosimulation Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Biosimulation Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Biosimulation Software Industry Trends Table 37. Biosimulation Software Industry Drivers Table 38. Biosimulation Software Industry Opportunities and Challenges Table 39. Biosimulation Software Industry Restraints Table 40. Global Biosimulation Software Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Biosimulation Software Revenue Market Share by Company (2021-2026) Table 42. Global Biosimulation Software Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Biosimulation Software Key Company Headquarters & Area Served Table 44. Global Biosimulation Software Company, Product Type & Application Table 45. Global Biosimulation Software Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Biosimulation Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Certara Company Information Table 49. Certara Business Overview Table 50. Certara Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Certara Biosimulation Software Product Portfolio Table 52. Certara Recent Development Table 53. Simulations Company Information Table 54. Simulations Business Overview Table 55. Simulations Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Simulations Biosimulation Software Product Portfolio Table 57. Simulations Recent Development Table 58. Dassault Systèmes Company Information Table 59. Dassault Systèmes Business Overview Table 60. Dassault Systèmes Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Dassault Systèmes Biosimulation Software Product Portfolio Table 62. Dassault Systèmes Recent Development Table 63. Schrödinger Company Information Table 64. Schrödinger Business Overview Table 65. Schrödinger Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Schrödinger Biosimulation Software Product Portfolio Table 67. Schrödinger Recent Development Table 68. Advanced Chemistry Company Information Table 69. Advanced Chemistry Business Overview Table 70. Advanced Chemistry Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Advanced Chemistry Biosimulation Software Product Portfolio Table 72. Advanced Chemistry Recent Development Table 73. Chemical Computing Company Information Table 74. Chemical Computing Business Overview Table 75. Chemical Computing Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Chemical Computing Biosimulation Software Product Portfolio Table 77. Chemical Computing Recent Development Table 78. Rosa & Co. Company Information Table 79. Rosa & Co. Business Overview Table 80. Rosa & Co. Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Rosa & Co. Biosimulation Software Product Portfolio Table 82. Rosa & Co. Recent Development Table 83. Genedata Company Information Table 84. Genedata Business Overview Table 85. Genedata Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Genedata Biosimulation Software Product Portfolio Table 87. Genedata Recent Development Table 88. Physiomics Company Information Table 89. Physiomics Business Overview Table 90. Physiomics Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Physiomics Biosimulation Software Product Portfolio Table 92. Physiomics Recent Development Table 93. In Silico Biosciences Company Information Table 94. In Silico Biosciences Business Overview Table 95. In Silico Biosciences Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. In Silico Biosciences Biosimulation Software Product Portfolio Table 97. In Silico Biosciences Recent Development Table 98. Allucent Company Information Table 99. Allucent Business Overview Table 100. Allucent Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Allucent Biosimulation Software Product Portfolio Table 102. Allucent Recent Development Table 103. OpenEye (Cadence) Company Information Table 104. OpenEye (Cadence) Business Overview Table 105. OpenEye (Cadence) Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. OpenEye (Cadence) Biosimulation Software Product Portfolio Table 107. OpenEye (Cadence) Recent Development Table 108. Cellworks Group Company Information Table 109. Cellworks Group Business Overview Table 110. Cellworks Group Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Cellworks Group Biosimulation Software Product Portfolio Table 112. Cellworks Group Recent Development Table 113. VeriSIM Life Company Information Table 114. VeriSIM Life Business Overview Table 115. VeriSIM Life Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. VeriSIM Life Biosimulation Software Product Portfolio Table 117. VeriSIM Life Recent Development Table 118. Netabolics SRL Company Information Table 119. Netabolics SRL Business Overview Table 120. Netabolics SRL Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Netabolics SRL Biosimulation Software Product Portfolio Table 122. Netabolics SRL Recent Development Table 123. Charnwood Discovery Company Information Table 124. Charnwood Discovery Business Overview Table 125. Charnwood Discovery Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Charnwood Discovery Biosimulation Software Product Portfolio Table 127. Charnwood Discovery Recent Development Table 128. The MathWorks Company Information Table 129. The MathWorks Business Overview Table 130. The MathWorks Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. The MathWorks Biosimulation Software Product Portfolio Table 132. The MathWorks Recent Development Table 133. ANSYS Company Information Table 134. ANSYS Business Overview Table 135. ANSYS Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. ANSYS Biosimulation Software Product Portfolio Table 137. ANSYS Recent Development Table 138. Instem Group of Companies Company Information Table 139. Instem Group of Companies Business Overview Table 140. Instem Group of Companies Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Instem Group of Companies Biosimulation Software Product Portfolio Table 142. Instem Group of Companies Recent Development Table 143. Insilico Medicine Company Information Table 144. Insilico Medicine Business Overview Table 145. Insilico Medicine Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Insilico Medicine Biosimulation Software Product Portfolio Table 147. Insilico Medicine Recent Development Table 148. SCM Company Information Table 149. SCM Business Overview Table 150. SCM Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. SCM Biosimulation Software Product Portfolio Table 152. SCM Recent Development Table 153. BioSymetrics Company Information Table 154. BioSymetrics Business Overview Table 155. BioSymetrics Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. BioSymetrics Biosimulation Software Product Portfolio Table 157. BioSymetrics Recent Development Table 158. Atomwise Company Information Table 159. Atomwise Business Overview Table 160. Atomwise Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Atomwise Biosimulation Software Product Portfolio Table 162. Atomwise Recent Development Table 163. insitro Company Information Table 164. insitro Business Overview Table 165. insitro Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. insitro Biosimulation Software Product Portfolio Table 167. insitro Recent Development Table 168. Clinithink Company Information Table 169. Clinithink Business Overview Table 170. Clinithink Biosimulation Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Clinithink Biosimulation Software Product Portfolio Table 172. Clinithink Recent Development Table 173. North America Biosimulation Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. North America Biosimulation Software Market Size by Country (2021-2026) & (US$ Million) Table 175. North America Biosimulation Software Market Share by Country (2021-2026) Table 176. North America Biosimulation Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. North America Biosimulation Software Market Share Forecast by Country (2027-2032) Table 178. Europe Biosimulation Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Europe Biosimulation Software Market Size by Country (2021-2026) & (US$ Million) Table 180. Europe Biosimulation Software Market Share by Country (2021-2026) Table 181. Europe Biosimulation Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Europe Biosimulation Software Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Biosimulation Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Biosimulation Software Market Size by Country (2021-2026) & (US$ Million) Table 185. Asia-Pacific Biosimulation Software Market Share by Country (2021-2026) Table 186. Asia-Pacific Biosimulation Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Asia-Pacific Biosimulation Software Market Share Forecast by Country (2027-2032) Table 188. Latin America Biosimulation Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Biosimulation Software Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Biosimulation Software Market Share by Country (2021-2026) Table 191. Latin America Biosimulation Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Biosimulation Software Market Share Forecast by Country (2027-2032) Table 193. Middle East & Africa Biosimulation Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East & Africa Biosimulation Software Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East & Africa Biosimulation Software Market Share by Country (2021-2026) Table 196. Middle East & Africa Biosimulation Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East & Africa Biosimulation Software Market Share Forecast by Country (2027-2032) Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Biosimulation Software Product Image Figure 3. Global Biosimulation Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 5. Global Biosimulation Software Market Share by Region: 2025 VS 2032 Figure 6. Global Biosimulation Software Market Share by Region (2021-2032) Figure 7. North America Biosimulation Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Biosimulation Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Biosimulation Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Biosimulation Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Biosimulation Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Independent Modules Image Figure 13. Global Independent Modules Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Integrated Software Platform Image Figure 15. Global Integrated Software Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Biosimulation Software Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Biosimulation Software Market Share by Type 2025 VS 2032 Figure 18. North America Biosimulation Software Market Size Share by Type (2021-2032) Figure 19. Europe Biosimulation Software Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Biosimulation Software Market Size Share by Type (2021-2032) Figure 21. Latin America Biosimulation Software Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Biosimulation Software Market Size Share by Type (2021-2032) Figure 23. Pharmaceuticals Image Figure 24. Global Pharmaceuticals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Medical Research Image Figure 26. Global Medical Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Others Image Figure 28. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Biosimulation Software Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Biosimulation Software Market Share by Application 2025 VS 2032 Figure 31. North America Biosimulation Software Market Size Share by Application (2021-2032) Figure 32. Europe Biosimulation Software Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Biosimulation Software Market Size Share by Application (2021-2032) Figure 34. Latin America Biosimulation Software Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Biosimulation Software Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Biosimulation Software Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Biosimulation Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Biosimulation Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Biosimulation Software Market Share by Country (2021-2032) Figure 41. Europe Biosimulation Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Biosimulation Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Biosimulation Software Market Share by Country (2021-2032) Figure 44. Asia-Pacific Biosimulation Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Biosimulation Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Biosimulation Software Market Share by Country (2021-2032) Figure 47. Latin America Biosimulation Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Biosimulation Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Biosimulation Software Market Share by Country (2021-2032) Figure 50. Middle East & Africa Biosimulation Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Biosimulation Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Biosimulation Software Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Independent Modules
  • Integrated Software Platform
Applications
  • Pharmaceuticals
  • Medical Research
  • Others
Companies covered
  • Certara
  • Simulations
  • Dassault Systèmes
  • Schrödinger
  • Advanced Chemistry
  • Chemical Computing
  • Rosa & Co.
  • Genedata
  • Physiomics
  • In Silico Biosciences
  • Allucent
  • OpenEye (Cadence)
  • Cellworks Group
  • VeriSIM Life
  • Netabolics SRL
  • Charnwood Discovery
  • The MathWorks
  • ANSYS
  • Instem Group of Companies
  • Insilico Medicine
  • SCM
  • BioSymetrics
  • Atomwise
  • insitro
  • Clinithink

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Biosimulation Software Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Biosimulation Software Market Size by Region (2021-2032)
  5. 1.4.1 Global Biosimulation Software Market Size by Region (2021-2026)
  6. 1.4.2 Global Biosimulation Software Market Size by Region (2027-2032)
  7. 1.5 Key Regions Biosimulation Software Market Size (2021-2032)
  8. 1.5.1 North America Biosimulation Software Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Biosimulation Software Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Biosimulation Software Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Biosimulation Software Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Biosimulation Software Market Size Growth Rate (2021-2032)
2 Biosimulation Software Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Independent Modules
  3. 2.1.2 Integrated Software Platform
  4. 2.2 Global Biosimulation Software Market Size by Type
  5. 2.2.1 Global Biosimulation Software Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Biosimulation Software Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Biosimulation Software Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Biosimulation Software Market Size by Regions
  9. 2.3.1 North America Biosimulation Software Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Biosimulation Software Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Biosimulation Software Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Biosimulation Software Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Biosimulation Software Market Size Breakdown by Type (2021-2026)
3 Biosimulation Software Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceuticals
  3. 3.1.2 Medical Research
  4. 3.1.3 Others
  5. 3.2 Global Biosimulation Software Market Size by Application
  6. 3.2.1 Global Biosimulation Software Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Biosimulation Software Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Biosimulation Software Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Biosimulation Software Market Size by Regions
  10. 3.3.1 North America Biosimulation Software Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Biosimulation Software Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Biosimulation Software Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Biosimulation Software Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Biosimulation Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Biosimulation Software Industry Trends
  2. 4.2 Biosimulation Software Industry Drivers
  3. 4.3 Biosimulation Software Industry Opportunities and Challenges
  4. 4.4 Biosimulation Software Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Biosimulation Software Revenue (2021-2026)
  2. 5.2 Global Biosimulation Software Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Biosimulation Software Key Company Headquarters & Area Served
  4. 5.4 Global Biosimulation Software Company, Product Type & Application
  5. 5.5 Global Biosimulation Software Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Biosimulation Software Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Biosimulation Software Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Biosimulation Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Certara
  2. 6.1.1 Certara Company Information
  3. 6.1.2 Certara Business Overview
  4. 6.1.3 Certara Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Certara Biosimulation Software Product Portfolio
  6. 6.1.5 Certara Recent Developments
  7. 6.2 Simulations
  8. 6.2.1 Simulations Company Information
  9. 6.2.2 Simulations Business Overview
  10. 6.2.3 Simulations Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Simulations Biosimulation Software Product Portfolio
  12. 6.2.5 Simulations Recent Developments
  13. 6.3 Dassault Systèmes
  14. 6.3.1 Dassault Systèmes Company Information
  15. 6.3.2 Dassault Systèmes Business Overview
  16. 6.3.3 Dassault Systèmes Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Dassault Systèmes Biosimulation Software Product Portfolio
  18. 6.3.5 Dassault Systèmes Recent Developments
  19. 6.4 Schrödinger
  20. 6.4.1 Schrödinger Company Information
  21. 6.4.2 Schrödinger Business Overview
  22. 6.4.3 Schrödinger Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Schrödinger Biosimulation Software Product Portfolio
  24. 6.4.5 Schrödinger Recent Developments
  25. 6.5 Advanced Chemistry
  26. 6.5.1 Advanced Chemistry Company Information
  27. 6.5.2 Advanced Chemistry Business Overview
  28. 6.5.3 Advanced Chemistry Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Advanced Chemistry Biosimulation Software Product Portfolio
  30. 6.5.5 Advanced Chemistry Recent Developments
  31. 6.6 Chemical Computing
  32. 6.6.1 Chemical Computing Company Information
  33. 6.6.2 Chemical Computing Business Overview
  34. 6.6.3 Chemical Computing Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Chemical Computing Biosimulation Software Product Portfolio
  36. 6.6.5 Chemical Computing Recent Developments
  37. 6.7 Rosa & Co.
  38. 6.7.1 Rosa & Co. Company Information
  39. 6.7.2 Rosa & Co. Business Overview
  40. 6.7.3 Rosa & Co. Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Rosa & Co. Biosimulation Software Product Portfolio
  42. 6.7.5 Rosa & Co. Recent Developments
  43. 6.8 Genedata
  44. 6.8.1 Genedata Company Information
  45. 6.8.2 Genedata Business Overview
  46. 6.8.3 Genedata Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Genedata Biosimulation Software Product Portfolio
  48. 6.8.5 Genedata Recent Developments
  49. 6.9 Physiomics
  50. 6.9.1 Physiomics Company Information
  51. 6.9.2 Physiomics Business Overview
  52. 6.9.3 Physiomics Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Physiomics Biosimulation Software Product Portfolio
  54. 6.9.5 Physiomics Recent Developments
  55. 6.10 In Silico Biosciences
  56. 6.10.1 In Silico Biosciences Company Information
  57. 6.10.2 In Silico Biosciences Business Overview
  58. 6.10.3 In Silico Biosciences Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 In Silico Biosciences Biosimulation Software Product Portfolio
  60. 6.10.5 In Silico Biosciences Recent Developments
  61. 6.11 Allucent
  62. 6.11.1 Allucent Company Information
  63. 6.11.2 Allucent Business Overview
  64. 6.11.3 Allucent Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Allucent Biosimulation Software Product Portfolio
  66. 6.11.5 Allucent Recent Developments
  67. 6.12 OpenEye (Cadence)
  68. 6.12.1 OpenEye (Cadence) Company Information
  69. 6.12.2 OpenEye (Cadence) Business Overview
  70. 6.12.3 OpenEye (Cadence) Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 OpenEye (Cadence) Biosimulation Software Product Portfolio
  72. 6.12.5 OpenEye (Cadence) Recent Developments
  73. 6.13 Cellworks Group
  74. 6.13.1 Cellworks Group Company Information
  75. 6.13.2 Cellworks Group Business Overview
  76. 6.13.3 Cellworks Group Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Cellworks Group Biosimulation Software Product Portfolio
  78. 6.13.5 Cellworks Group Recent Developments
  79. 6.14 VeriSIM Life
  80. 6.14.1 VeriSIM Life Company Information
  81. 6.14.2 VeriSIM Life Business Overview
  82. 6.14.3 VeriSIM Life Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 VeriSIM Life Biosimulation Software Product Portfolio
  84. 6.14.5 VeriSIM Life Recent Developments
  85. 6.15 Netabolics SRL
  86. 6.15.1 Netabolics SRL Company Information
  87. 6.15.2 Netabolics SRL Business Overview
  88. 6.15.3 Netabolics SRL Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Netabolics SRL Biosimulation Software Product Portfolio
  90. 6.15.5 Netabolics SRL Recent Developments
  91. 6.16 Charnwood Discovery
  92. 6.16.1 Charnwood Discovery Company Information
  93. 6.16.2 Charnwood Discovery Business Overview
  94. 6.16.3 Charnwood Discovery Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Charnwood Discovery Biosimulation Software Product Portfolio
  96. 6.16.5 Charnwood Discovery Recent Developments
  97. 6.17 The MathWorks
  98. 6.17.1 The MathWorks Company Information
  99. 6.17.2 The MathWorks Business Overview
  100. 6.17.3 The MathWorks Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 The MathWorks Biosimulation Software Product Portfolio
  102. 6.17.5 The MathWorks Recent Developments
  103. 6.18 ANSYS
  104. 6.18.1 ANSYS Company Information
  105. 6.18.2 ANSYS Business Overview
  106. 6.18.3 ANSYS Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 ANSYS Biosimulation Software Product Portfolio
  108. 6.18.5 ANSYS Recent Developments
  109. 6.19 Instem Group of Companies
  110. 6.19.1 Instem Group of Companies Company Information
  111. 6.19.2 Instem Group of Companies Business Overview
  112. 6.19.3 Instem Group of Companies Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Instem Group of Companies Biosimulation Software Product Portfolio
  114. 6.19.5 Instem Group of Companies Recent Developments
  115. 6.20 Insilico Medicine
  116. 6.20.1 Insilico Medicine Company Information
  117. 6.20.2 Insilico Medicine Business Overview
  118. 6.20.3 Insilico Medicine Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Insilico Medicine Biosimulation Software Product Portfolio
  120. 6.20.5 Insilico Medicine Recent Developments
  121. 6.21 SCM
  122. 6.21.1 SCM Company Information
  123. 6.21.2 SCM Business Overview
  124. 6.21.3 SCM Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 SCM Biosimulation Software Product Portfolio
  126. 6.21.5 SCM Recent Developments
  127. 6.22 BioSymetrics
  128. 6.22.1 BioSymetrics Company Information
  129. 6.22.2 BioSymetrics Business Overview
  130. 6.22.3 BioSymetrics Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 BioSymetrics Biosimulation Software Product Portfolio
  132. 6.22.5 BioSymetrics Recent Developments
  133. 6.23 Atomwise
  134. 6.23.1 Atomwise Company Information
  135. 6.23.2 Atomwise Business Overview
  136. 6.23.3 Atomwise Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Atomwise Biosimulation Software Product Portfolio
  138. 6.23.5 Atomwise Recent Developments
  139. 6.24 insitro
  140. 6.24.1 insitro Company Information
  141. 6.24.2 insitro Business Overview
  142. 6.24.3 insitro Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 insitro Biosimulation Software Product Portfolio
  144. 6.24.5 insitro Recent Developments
  145. 6.25 Clinithink
  146. 6.25.1 Clinithink Company Information
  147. 6.25.2 Clinithink Business Overview
  148. 6.25.3 Clinithink Biosimulation Software Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Clinithink Biosimulation Software Product Portfolio
  150. 6.25.5 Clinithink Recent Developments
7 North America
  1. 7.1 North America Biosimulation Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Biosimulation Software Market Size by Country (2021-2026)
  3. 7.3 North America Biosimulation Software Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Biosimulation Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Biosimulation Software Market Size by Country (2021-2026)
  3. 8.3 Europe Biosimulation Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biosimulation Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Biosimulation Software Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Biosimulation Software Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Biosimulation Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Biosimulation Software Market Size by Country (2021-2026)
  3. 10.3 South America Biosimulation Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biosimulation Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Biosimulation Software Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Biosimulation Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst